Protara Therapeutics, Inc. TARA

Full chart Compare
Set alert

Price alert · TARA

All alert types
2.41 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:01 PM EST

2.41 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

2.37 Day range 2.54
2.32 52-week range 7.56
YTD
-54.78%
1 year
-52.93%

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 26.40 +995.4% upside
Target (low)
14.00
Target (mean)
26.40
Target (high)
50.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy4
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 4
  • 2 months ago 5
  • 3 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

TARA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.54333-0.61 – -0.51-0.90+39.6%00.0%3
Next quarter-0.62-0.67 – -0.55-0.97+36.1%00.0%3
Current year-2.30-2.38 – -2.22-3.57+35.6%00.0%3
Next year-2.28-2.67 – -1.54-2.30+0.7%00.0%3

Upgrades and downgrades

The latest rating changes

TARA analyst upgrades and downgrades
DateFirmActionFromTo
Dec 6, 2024GuggenheimReiteratedBuyBuy
Dec 6, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 12, 2024OppenheimerMaintainedOutperformOutperform
Aug 8, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 6, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 22, 2024OppenheimerMaintainedOutperformOutperform
Apr 8, 2024HC Wainwright & Co.MaintainedBuyBuy
Mar 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 4, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 8, 2023HC Wainwright & Co.Reiterated—Buy
May 1, 2023HC Wainwright & Co.Reiterated—Buy
Mar 9, 2023HC Wainwright & Co.Reiterated—Buy
Aug 10, 2022HC Wainwright & Co.Maintained—Buy
May 9, 2022HC Wainwright & Co.Maintained—Buy
Nov 8, 2021OppenheimerMaintained—Outperform
Jun 4, 2021HC Wainwright & Co.Initiated—Buy
Oct 19, 2020Cowen & Co.Initiated—Outperform
Jul 29, 2020GuggenheimInitiated—Buy